Neogen (NEOG) Cash from Investing Activities (2010 - 2026)
Neogen (NEOG) recorded quarterly Cash from Investing Activities of -$11.6 million in Q1 2026, up 0.97% quarter-over-quarter from -$11.7 million in Q4 2025, and up 64.42% on a YoY basis from -$7.0 million in Q1 2025.
Neogen (NEOG) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Neogen's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$11.6 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 64.42% year-over-year to -$11.6 million; the TTM figure through Feb 2026 stood at $58.6 million (up 158.13% YoY), while the FY2025 annual figure was -$99.2 million, down 238.45% from the prior year.
- Cash from Investing Activities was -$11.6 million for Q1 2026 at Neogen, up from -$11.7 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $97.7 million in Q3 2025 to a low of -$33.7 million in Q3 2024.
- Historically, Cash from Investing Activities has averaged $6.7 million across 5 years, with a median of -$11.7 million in 2025.
- The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities surged 421.32% in 2022, then sank 354.84% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at $93.0 million in 2022, then sank by 87.6% to $11.5 million in 2023, then tumbled by 248.73% to -$17.2 million in 2024, then surged by 31.99% to -$11.7 million in 2025, then increased by 0.97% to -$11.6 million in 2026.
- The last three Cash from Investing Activities figures came in at -$11.6 million (Q1 2026), -$11.7 million (Q4 2025), and $97.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Neogen | 1.98 Bn | 1.82 Bn | 99.00 Mn | -11.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -11.56 Mn |
| Feb 28, 2026 | -11.56 Mn |
| Nov 30, 2025 | -11.67 Mn |
| Nov 30, 2025 | -11.67 Mn |
| Aug 31, 2025 | 97.73 Mn |
| Aug 31, 2025 | 97.73 Mn |
| May 31, 2025 | -15.90 Mn |
| May 31, 2025 | -15.90 Mn |
| Feb 28, 2025 | -32.48 Mn |
| Feb 28, 2025 | -32.48 Mn |
| Nov 30, 2024 | -17.16 Mn |
| Nov 30, 2024 | -17.16 Mn |
| Aug 31, 2024 | -33.66 Mn |
| Aug 31, 2024 | -33.66 Mn |
| May 31, 2024 | -17.52 Mn |
| May 31, 2024 | -17.52 Mn |
| Feb 29, 2024 | -14.64 Mn |
| Feb 29, 2024 | -14.64 Mn |
| Nov 30, 2023 | 11.54 Mn |
| Nov 30, 2023 | 11.54 Mn |